drugset / Trial / NCT00960986

A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

NCT00960986

Phase 4 Completed 249 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess nausea severity in response to four different drug dosing strategies of Duloxetine (30 mg with food, 60 mg with food, 30 mg without food, and 60 mg without food) in Korean patients with major depressive disorder (MDD).

Timeline

Start
2009-08
Primary completion
2011-02
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral